Third-generation tyrosine kinase inhibitor in the treatment of epidermal growth factor receptor mutated squamous cell lung cancer: a tailored therapy approach
Author(s) -
Francesco Cortiula,
Giovanna De Maglio,
Maria Giulia Cangi,
Lorenzo Gerratana,
C. Lisanti,
Salvatore Bonura,
Gianpiero Fasola,
Alessandro Follador
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2018.12.42
Subject(s) - cancer research , epidermal growth factor receptor , tyrosine kinase , lung cancer , squamous cell cancer , tyrosine kinase inhibitor , medicine , epidermal growth factor , receptor tyrosine kinase , receptor , cancer , oncology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom